PROCASTAT

Welcome to the Brand page for “PROCASTAT”, which is offered here for Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations of the treatment of prostate cancer; pharmaceutical preparations containing nucleic acid for use in the treatment of prostate cancer;instruments and apparatus for the administration of gene therapy, syringes, scalpels, catheters and tubes, for medical services surgical and medical apparatus and instruments, syringes, scalpels, catheters, tubes for medical services;.

Its status is currently believed to be active. Its class is unavailable. “PROCASTAT” is believed to be currently owned by “Oxford BioMedica plc”.